DH

dievini Hopp Biotech Holding

Walldorf, Germany

About

Dievini is an active investor in Life and Health Sciences companies and is dedicated to the coaching and support of the management teams in corporate and business development. Dievini’s focus is on innovative therapeutics and diagnostics, which are shown to lead to novel treatment regimens allowing doctors to treat patients with life-threatening diseases better and safer than they can today. Dievini, therefore, is largely invested in companies with unique and first-in-class diagnosis and therapy approaches. The indication focus is in oncology, neurology, infectious diseases, cell therapy and drug delivery systems. In molecular diagnostics, the primary focus is on systems and products in personalized medicine to support and allow individually improved therapy success with reduced adverse events. Dievini’s activities are geographically centered in Germany and Europe. The companies invested in are actively supported in their global development and business activities by dievini.

Position in the VCSift Database

  • 3,884 investors in VCSift focus on the healthtech sector.
  • 7 investors are based in Walldorf, Baden-Wurttemberg, Germany.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Stages
series-c

Contact Information

co•••••@dievini.com

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like dievini

Search Investors